Articles By Jack Cush, MD
RheumNow Podcast – Falling or Falling in Love?
By Jack Cush, MD
06 May 2021
Dr. Jack Cush reviews the best journal articles from the past week on RheumNow.com.
Read Article
Unique Oral Microbiome in Early and Pre-Clinical RA
By Jack Cush, MD
06 May 2021
An oral microbiome study of rheumatoid arthritis patients suggests that periodontal condition in patients with early rheumatoid arthritis and individuals at risk of RA.
Read Article
ARTIC REWIND - Don't Half DMARD Therapy
By Jack Cush, MD
06 May 2021
The ARTIC-REWIND study examined rheumatoid arthritis (RA) patients in remission on conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) to see if they could "step-down" their csDMARDs theray; but the study showed that 25% those who went on half-dose experienced disease flares
Read Article
Drug Monitoring Ineffective with Infliximab Treatment
By Jack Cush, MD
05 May 2021
The predictive value of therapeutic drug monitoring (TDM) while on biologics is debateable; gastroenterology routinely relies on TDM, while rheumatologists do not.
Read Article
Childhood Lupus May Hamper Adult Careers
By Jack Cush, MD
04 May 2021
Long-term outcomes of kids with childhood-onset systemic lupus erythematosus (cSLE) are uncommon, but this cSLE cohort analysis suggests that SLE significantly impacts their future education, vocation, and employment as they reach adulthood.
Read Article
Autoimmune Thyroid Disease in Women
By Jack Cush, MD
04 May 2021
JAMA has posted an insights article reviewing autoimmune thyroid disease in women. Thyroid autoimmunity has a higher prevalence in women and with increasing age. Similar to many autoimmune disorders, thyroid disease is more common in women than in men.
Read Article
Higher Cardiovascular Risks with Systemic Lupus Erythematosus
By Jack Cush, MD
03 May 2021
The Journal of the American College of Cardiology has published the results of a study showing that patients with systemic lupus erythematosus (SLE) have an increased risk of heart failure (HF) and other long-term cardiovascular outcomes.
Read Article
Uric Acid: A Major Player in the Metabolic Syndrome
By Jack Cush, MD
03 May 2021
An open source, free read from the European Journal of Internal Medicine discusses how uric acid has evolved from the toxic cause of gout and nephrolithiasis and evolved, by way of science, into a pleiotropic recidivist in the evolution of obesity, diabetes, insulin resistance, renal disease, hypertension, fatty liver, and cardiovascular disease.
Read Article
RheumNow Podcast – Uppers and Downers
By Jack Cush, MD
30 April 2021
Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com.
Read Article
Predictors of Methotrexate Toxicity
By Jack Cush, MD
30 April 2021
A metanalysis showed that while adverse events (AEs) are common when methotrexate is used in rheumatoid arthritis or inflammatory arthritis patients, serious AEs ranged from 2.1 to 9.5% and drug discontinuations ranged from 6.7% to 15.5%, mostly due to gastrointestinal events.
Read Article